Macaya Douoguih, MD, head of clinical development and medical affairs for vaccines, said during a symposium held by Johns Hopkins University and the University of Washington, that Johnson & Johnson has four clinical trials planned for its vaccine in adolescents. The first will test the shot in kids ages 12 to 17; another will test the shot in kids ages 2 to 11; the third will test it in kids younger than 2; and the fourth will test it in immunocompromised children ages 1 to 17.
The shot is now authorized only for those 18 years and older.
“While we are encouraged by the progress made with vaccinations, we recognize that a great deal more work is needed as this pandemic continues to affect the world and as the unvaccinated continue to be at risk,” Dr. Douoguih said, according to The Hill.
Johnson & Johnson said it plans to enroll at least 4,500 people across the four studies.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
